JP2014521958A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014521958A5 JP2014521958A5 JP2014523039A JP2014523039A JP2014521958A5 JP 2014521958 A5 JP2014521958 A5 JP 2014521958A5 JP 2014523039 A JP2014523039 A JP 2014523039A JP 2014523039 A JP2014523039 A JP 2014523039A JP 2014521958 A5 JP2014521958 A5 JP 2014521958A5
- Authority
- JP
- Japan
- Prior art keywords
- fluid
- cancer
- serous
- cells
- ligand
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161512576P | 2011-07-28 | 2011-07-28 | |
| US61/512,576 | 2011-07-28 | ||
| PCT/US2012/048452 WO2013016600A2 (en) | 2011-07-28 | 2012-07-27 | Methods and reagents for diagnosing conditions and characterization of tumor cells associated with serous fluids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014521958A JP2014521958A (ja) | 2014-08-28 |
| JP2014521958A5 true JP2014521958A5 (https=) | 2015-09-03 |
Family
ID=46650901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014523039A Pending JP2014521958A (ja) | 2011-07-28 | 2012-07-27 | 胸腔内液若しくは漿液と関連する腫瘍細胞の特徴づけによる癌の診断方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20140295426A1 (https=) |
| EP (1) | EP2737317A2 (https=) |
| JP (1) | JP2014521958A (https=) |
| IL (1) | IL230687A0 (https=) |
| TW (1) | TW201312117A (https=) |
| WO (1) | WO2013016600A2 (https=) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6238856B2 (ja) * | 2014-08-25 | 2017-11-29 | シスメックス株式会社 | 尿中異型細胞の分析方法、尿分析装置および体液中異型細胞の分析方法 |
| WO2017054075A1 (en) * | 2015-09-28 | 2017-04-06 | The Governing Council Of The University Of Toronto | Device for magnetic profiling of particles in a flow |
| US10696961B2 (en) | 2017-12-01 | 2020-06-30 | Global Life Sciences Solutions Usa Llc | Magnetic cell isolation techniques |
| AU2018376657B2 (en) * | 2017-12-01 | 2024-07-25 | Global Life Sciences Solutions Usa Llc | Methods for cell enrichment and isolation |
| WO2021119470A1 (en) * | 2019-12-12 | 2021-06-17 | University Of Miami | Materials and methods for extracellular vesicle detection |
| US12159700B2 (en) | 2020-04-22 | 2024-12-03 | Iovance Biotherapeutics, Inc. | Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy |
| EP4146794A1 (en) | 2020-05-04 | 2023-03-15 | Iovance Biotherapeutics, Inc. | Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy |
| TW202208616A (zh) | 2020-05-04 | 2022-03-01 | 美商艾歐凡斯生物治療公司 | 改良之腫瘤反應性ｔ細胞的選擇 |
| US20230372397A1 (en) | 2020-10-06 | 2023-11-23 | Iovance Biotherapeutics, Inc. | Treatment of nsclc patients with tumor infiltrating lymphocyte therapies |
| WO2022076606A1 (en) | 2020-10-06 | 2022-04-14 | Iovance Biotherapeutics, Inc. | Treatment of nsclc patients with tumor infiltrating lymphocyte therapies |
| TW202241468A (zh) | 2020-12-11 | 2022-11-01 | 美商艾歐凡斯生物治療公司 | 用腫瘤浸潤性淋巴球療法與ｂｒａｆ抑制劑及／或ｍｅｋ抑制劑組合治療癌症患者 |
| US20240123067A1 (en) | 2020-12-17 | 2024-04-18 | Iovance Biotherapeutics, Inc. | Treatment of cancers with tumor infiltrating lymphocyte therapies |
| CA3202483A1 (en) | 2020-12-17 | 2022-06-23 | Maria Fardis | Treatment with tumor infiltrating lymphocyte therapies in combination with ctla-4 and pd-1 inhibitors |
| TW202242085A (zh) | 2020-12-31 | 2022-11-01 | 美商艾歐凡斯生物治療公司 | 供自動生產腫瘤浸潤淋巴球的裝置和方法 |
| WO2022187741A2 (en) | 2021-03-05 | 2022-09-09 | Iovance Biotherapeutics, Inc. | Tumor storage and cell culture compositions |
| WO2022198141A1 (en) | 2021-03-19 | 2022-09-22 | Iovance Biotherapeutics, Inc. | Methods for tumor infiltrating lymphocyte (til) expansion related to cd39/cd69 selection and gene knockout in tils |
| AU2022246174A1 (en) | 2021-03-25 | 2023-09-14 | Iovance Biotherapeutics, Inc. | Methods and compositions for t-cell coculture potency assays and use with cell therapy products |
| EP4326287A2 (en) | 2021-04-19 | 2024-02-28 | Iovance Biotherapeutics, Inc. | Chimeric costimulatory receptors, chemokine receptors, and the use of same in cellular immunotherapies |
| WO2022245754A1 (en) | 2021-05-17 | 2022-11-24 | Iovance Biotherapeutics, Inc. | Pd-1 gene-edited tumor infiltrating lymphocytes and uses of same in immunotherapy |
| US20240342285A1 (en) | 2021-07-28 | 2024-10-17 | Iovance Biotherapeutics, Inc. | Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with kras inhibitors |
| IL311333A (en) | 2021-09-09 | 2024-05-01 | Iovance Biotherapeutics Inc | Processes for generating til products using pd-1 talen knockdown |
| EP4404969A1 (en) | 2021-09-24 | 2024-07-31 | Iovance Biotherapeutics, Inc. | Expansion processes and agents for tumor infiltrating lymphocytes |
| WO2023077015A2 (en) | 2021-10-27 | 2023-05-04 | Iovance Biotherapeutics, Inc. | Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy |
| EP4430167A1 (en) | 2021-11-10 | 2024-09-18 | Iovance Biotherapeutics, Inc. | Methods of expansion treatment utilizing cd8 tumor infiltrating lymphocytes |
| US20250101380A1 (en) | 2022-01-28 | 2025-03-27 | Iovance Biotherapeutics, Inc. | Tumor infiltrating lymphocytes engineered to express payloads |
| CA3248034A1 (en) | 2022-04-15 | 2023-10-19 | Iovance Biotherapeutics, Inc. | METHODS FOR EXPANSION OF TIL CELLS BY MEANS OF SPECIFIC CYTOKINE COMBINATIONS AND/OR AKT INHIBITOR TREATMENT |
| US20260008990A1 (en) | 2022-07-06 | 2026-01-08 | Iovance Biotherapeutics, Inc. | Devices and processes for automated production of tumor infiltrating lymphocytes |
| EP4565683A1 (en) | 2022-08-01 | 2025-06-11 | Iovance Biotherapeutics, Inc. | Chimeric costimulatory receptors, chemokine receptors, and the use of same in cellular immunotherapies |
| WO2024098027A1 (en) | 2022-11-04 | 2024-05-10 | Iovance Biotherapeutics, Inc. | Methods for tumor infiltrating lymphocyte (til) expansion related to cd39/cd103 selection |
| EP4623072A2 (en) | 2022-11-21 | 2025-10-01 | Iovance Biotherapeutics, Inc. | Two-dimensional processes for the expansion of tumor infiltrating lymphocytes and therapies therefrom |
| AU2024296516A1 (en) | 2023-07-13 | 2026-01-22 | Iovance Biotherapeutics, Inc. | Cytokine encoding lentiviral vectors and uses thereof for making tumor infiltrating lymphocytes |
| AU2024292473A1 (en) | 2023-07-19 | 2026-01-29 | Iovance Biotherapeutics, Inc. | Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with trop-2 targeting adc |
| WO2025101484A1 (en) | 2023-11-06 | 2025-05-15 | Iovance Biotherapeutics, Inc. | Treatment of endometrial cancers with tumor infiltrating lymphocyte therapies |
| WO2026035866A1 (en) | 2024-08-07 | 2026-02-12 | Iovance Biotherapeutics, Inc. | Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with a lag-3 inhibitor and a pd-1 inhibitor |
| WO2026050217A2 (en) | 2024-08-27 | 2026-03-05 | Iovance Biotherapeutics, Inc. | Engineered artificial antigen presenting cells and lipid nanoparticles for tumor infiltrating lymphocyte expansion |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4939240A (en) | 1983-03-04 | 1990-07-03 | Health Research, Inc. | Monoclonal antibodies to human breast carcinoma cells and their use in diagnosis and therapy |
| JPH0763389B2 (ja) * | 1986-10-28 | 1995-07-12 | 協和醗酵工業株式会社 | 抗ヒト中皮細胞単クローン性抗体 |
| EP0491867B1 (en) | 1989-09-15 | 1996-11-27 | Genetic Systems Corporation | Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer |
| DE69306803T2 (de) | 1992-09-17 | 1997-05-15 | Merck Patent Gmbh | Kleinzelliger lungenkarzinom-spezifischer antikörper und antigenen |
| NO180658C (no) * | 1994-03-10 | 1997-05-21 | Oeystein Fodstad | Fremgangsmåte og anordning for deteksjon av spesifikke målceller i spesialiserte eller blandede cellepopulasjoner og opplösninger som inneholder blandede cellepopulasjoner |
| US6136182A (en) | 1996-06-07 | 2000-10-24 | Immunivest Corporation | Magnetic devices and sample chambers for examination and manipulation of cells |
| US6790366B2 (en) | 1996-06-07 | 2004-09-14 | Immunivest Corporation | Magnetic separation apparatus and methods |
| US6890426B2 (en) | 1996-06-07 | 2005-05-10 | Immunivest Corporation | Magnetic separation apparatus and methods |
| EP0920627B1 (en) | 1996-06-07 | 2004-05-12 | Immunivest Corporation | Magnetic separation employing external and internal gradients |
| US6660159B1 (en) | 1996-06-07 | 2003-12-09 | Immunivest Corporation | Magnetic separation apparatus and methods |
| US7282350B2 (en) | 1998-02-12 | 2007-10-16 | Immunivest Corporation | Labeled cell sets for use as functional controls in rare cell detection assays |
| WO1999041613A1 (en) | 1998-02-12 | 1999-08-19 | Immunivest | Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
| US6623982B1 (en) | 1999-07-12 | 2003-09-23 | Immunivest Corporation | Increased separation efficiency via controlled aggregation of magnetic nanoparticles |
| DE60214827T2 (de) | 2001-02-12 | 2007-03-29 | Immunivest Corp., Wilmington | Kassette als behälter eines probenexemplars für die optische analyse |
| EP1425294B2 (en) * | 2001-08-23 | 2012-12-12 | Veridex, LLC | Analysis of circulating tumor cells, fragments, and debris |
| GB2424273B (en) * | 2002-11-14 | 2007-06-27 | Univ Nottingham | Method for preparing tumour marker protein |
| US7666583B2 (en) * | 2004-02-19 | 2010-02-23 | Yale University | Identification of cancer protein biomarkers using proteomic techniques |
| US20060024824A1 (en) * | 2004-07-16 | 2006-02-02 | Steven Woodside | Magnetic cell separation method |
| JP5086241B2 (ja) * | 2005-04-21 | 2012-11-28 | カリフォルニア インスティチュート オブ テクノロジー | パリレンメンブレンフィルターの使用 |
| US7846743B2 (en) * | 2005-04-21 | 2010-12-07 | California Institute Of Technology | Uses of parylene membrane filters |
| FR2896881B1 (fr) * | 2006-01-31 | 2008-04-18 | Biomerieux Sa | Procede de dosage du prongf pour le diagnostic in vitro du cancer du sein et utilisation du prongf en therapie |
| EP2054083B1 (en) * | 2006-08-23 | 2013-11-27 | Korea Research Institute of Bioscience and Biotechnology | A pharmaceutical composition for treating cholangiocarcinoma, a method for inhibiting growth or invasion of cholangiocarcinoma and a method for treating cholangiocarcinoma |
| EP2037265A1 (en) * | 2007-09-17 | 2009-03-18 | Adnagen AG | Solid phase cell isolation and/or enrichment method |
| WO2010102177A1 (en) * | 2009-03-06 | 2010-09-10 | Becton, Dickinson And Company | Glycodelin monoclonal antibodies and methods for their use in the detection of ovarian cancer |
-
2012
- 2012-07-27 US US14/235,185 patent/US20140295426A1/en not_active Abandoned
- 2012-07-27 TW TW101127107A patent/TW201312117A/zh unknown
- 2012-07-27 JP JP2014523039A patent/JP2014521958A/ja active Pending
- 2012-07-27 WO PCT/US2012/048452 patent/WO2013016600A2/en not_active Ceased
- 2012-07-27 EP EP12746193.7A patent/EP2737317A2/en not_active Withdrawn
-
2014
- 2014-01-28 IL IL230687A patent/IL230687A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014521958A5 (https=) | ||
| Lone et al. | Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments | |
| Pang et al. | Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis | |
| Vaidyanathan et al. | Cancer diagnosis: from tumor to liquid biopsy and beyond | |
| Wei et al. | Plasma extracellular vesicles detected by Single Molecule array technology as a liquid biopsy for colorectal cancer | |
| Drucker et al. | Comparative performance of different methods for circulating tumor cell enrichment in metastatic breast cancer patients | |
| Jiawei et al. | Magnetic bead-based adsorption strategy for exosome isolation | |
| Li et al. | Exosomal proteins as potential markers of tumor diagnosis | |
| Hyun et al. | Negative enrichment of circulating tumor cells using a geometrically activated surface interaction chip | |
| Chung et al. | An electrical biosensor for the detection of circulating tumor cells | |
| Li et al. | Strategies for enrichment of circulating tumor cells | |
| Ning et al. | Improvement of specific detection of circulating tumor cells using combined CD45 staining and fluorescence in situ hybridization | |
| WO2013016600A3 (en) | Methods for diagnosing cancer by characterization of tumor cells associated with pleural or serous fluids | |
| WO2015101163A1 (zh) | 抗hla-g的单克隆抗体偶联免疫磁珠在肿瘤细胞分选中的应用 | |
| Gao et al. | Analysis of circulating tumor cells from lung cancer patients with multiple biomarkers using high-performance size-based microfluidic chip | |
| US10094837B2 (en) | Cadherins as cancer biomarkers | |
| CN115427810A (zh) | 用于从生物流体样品中富集细胞外囊泡的方法 | |
| Khondakar et al. | Prospects in cancer diagnosis: exosome-chip for liquid biopsy | |
| CN106701684A (zh) | 一种高效率循环肿瘤细胞富集方法 | |
| Li et al. | Circulating tumor cells are a good predictor of tumor recurrence in clinical patients with gastric cancer | |
| CN111830249A (zh) | 用于纯化分离及分析非典型循环肿瘤细胞的方法的用途及非典型循环肿瘤细胞的用途 | |
| Montoya Mira et al. | Label-free enrichment of rare unconventional circulating neoplastic cells using a microfluidic dielectrophoretic sorting device | |
| Manicone et al. | Critical issues in the clinical application of liquid biopsy in non-small cell lung cancer | |
| Liu et al. | Identification of high independent prognostic value of nanotechnology based circulating tumor cell enumeration in first-line chemotherapy for metastatic breast cancer patients | |
| Yi et al. | Exosomal proteomics: unveiling novel insights into lung cancer |